Found 6 matching trials
Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome) PHASE3 This is a multi-center, Phase III study to evaluate the safety and tolerabi...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Ropinirole Tablets In Young Patients With Restless Legs Syndrome PHASE1 This is a two-period dose rising study of Ropinirole Immediate Release in a...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration) PHASE2 This is a multicenter, placebo controlled, parallel group, double-blind, ra...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's PHASE3 This study was designed to compare the effectiveness and tolerability of a ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients PHASE4 To determine if there is any difference in the presence of retinal deterior...
Show More Location
248.538.00007 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole PHASE3 Restless Legs Syndrome (RLS) study in adults comparing immediate release ro...
Show More Location
GSK Investigational Site
Learn More & Join Trial